We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

89 hedge funds and large institutions have $711M invested in BELLUS Health Inc. in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 7

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

144% more capital invested

Capital invested by funds: $291M → $711M (+$420M)

62% more funds holding

Funds holding: 5589 (+34)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

26% less call options, than puts

Call options by funds: $11.6M | Put options by funds: $15.6M

Holders
89
Holders Change
+34
Holders Change %
+61.82%
% of All Funds
1.37%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
42
Increased
20
Reduced
19
Closed
7
Calls
$11.6M
Puts
$15.6M
Net Calls
-$3.99M
Net Calls Change
-$8.65M
Name Holding Trade Value Shares
Change
Change in
Stake
JF
51
Jump Financial
Illinois
$616K +$508K +76,493 New
Alyeska Investment Group
52
Alyeska Investment Group
Illinois
$604K +$498K +75,000 New
Morgan Stanley
53
Morgan Stanley
New York
$481K -$118K -17,803 -23%
Geode Capital Management
54
Geode Capital Management
Massachusetts
$457K
D.E. Shaw & Co
55
D.E. Shaw & Co
New York
$457K +$376K +56,713 New
IC
56
Ikarian Capital
Texas
$402K -$4.61M -694,616 -93%
FDCDDQ
57
Federation des caisses Desjardins du Quebec
Quebec, Canada
$359K +$203K +30,637 +208%
Walleye Trading
58
Walleye Trading
New York
$342K +$282K +42,424 New
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$273K +$153K +23,024 +212%
WMSA
60
Weiss Multi-Strategy Advisers
New York
$269K -$916 -138 -0.4%
Renaissance Technologies
61
Renaissance Technologies
New York
$230K +$190K +28,638 New
National Bank of Canada
62
National Bank of Canada
Quebec, Canada
$214K +$180K +27,092 New
Bank of America
63
Bank of America
North Carolina
$194K +$160K +24,103 New
Verition Fund Management
64
Verition Fund Management
Connecticut
$161K +$66.4K +10,000 +100%
PCM
65
Pinz Capital Management
New York
$145K +$119K +18,000 New
TI
66
Trexquant Investment
Connecticut
$143K +$118K +17,778 New
Walleye Capital
67
Walleye Capital
New York
$140K +$116K +17,445 New
Jane Street
68
Jane Street
New York
$134K -$139K -20,877 -56%
SC
69
Shay Capital
New York
$126K +$104K +15,646 New
TSS
70
Two Sigma Securities
New York
$126K +$104K +15,657 New
XT
71
XTX Topco
Cayman Islands
$92K +$76.1K +11,474 New
ProShare Advisors
72
ProShare Advisors
Maryland
$89K +$73.2K +11,031 New
Simplex Trading
73
Simplex Trading
Illinois
$85K +$29.1K +4,392 +71%
CL
74
CSS LLC
Illinois
$60K -$267K -40,200 -84%
UBS Group
75
UBS Group
Switzerland
$51K +$27.7K +4,178 +197%

BLU Hedge Fund Activity: Q4 2021 in Review

89 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2021, worth a combined $711M — up 144% from $291M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new BLU positions and 7 closed out — a net gain of 35 holders — while 20 added to existing stakes and 19 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $67.9M. The largest seller was Acuta Capital Partners, cutting an estimated $9.84M.

  • 89 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2021, up from 55 in Q3 2021.
  • Funds reported $711M of BELLUS Health Inc. stock for Q4 2021, up 144% quarter-over-quarter.
  • 42 funds opened new BELLUS Health Inc. positions in Q4 2021 and 7 closed out, a net change of +35 holders.
  • The largest BELLUS Health Inc. buyer in Q4 2021 was RA Capital Management, an estimated $67.9M added.
  • The largest BELLUS Health Inc. seller in Q4 2021 was Acuta Capital Partners, an estimated $9.84M sold.

Based on aggregated 13F filings for Q4 2021.